Millendo Therapeutics
Signal active
Organization
Contact Information
Overview
Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.
About
Industries
Biotechnology, Life Science, Therapeutics
Founded
2011
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Millendo Therapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Therapeutics sector. The company focuses on Biotechnology and has secured $13.8B in funding across 72 round(s). With a team of 11-50 employees, Millendo Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Millendo Therapeutics, raised $16.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
4
Lead Investors
0
Total Funding Amount
$191.5M
Details
3
Millendo Therapeutics has raised a total of $191.5M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2016 | Early Stage Venture | 62.0M | ||
| 2013 | Private Equity | 8.5M | ||
| 2012 | Early Stage Venture | 16.0M |
Investors
Millendo Therapeutics is funded by 28 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Millendo Therapeutics | - | FUNDING ROUND - Millendo Therapeutics | 62.0M |
| 5AM Ventures | - | FUNDING ROUND - 5AM Ventures | 62.0M |
| Millendo Therapeutics | - | FUNDING ROUND - Millendo Therapeutics | 16.0M |
| Ann Arbor SPARK | - | FUNDING ROUND - Ann Arbor SPARK | 16.0M |
Recent Activity
There is no recent news or activity for this profile.